{
  "schema_version": "0.1.0",
  "case_id": "HR-ET010",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ET010",
    "display_name": "Jack London",
    "aliases": [
      "John Griffith Chaney"
    ],
    "sex": "male",
    "era": "Early 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1876-01-12",
          "display": "January 12, 1876",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1876",
              "display": "1876",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1916-11-22",
          "display": "November 22, 1916",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1916",
              "display": "1916",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ET010-SYN",
      "ssn": "000-10-4482",
      "date_of_birth": "1987-01-12",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Eleanor Whitcombe-Ibe, MD",
      "fictional_consultant": {
        "name": "Teodor Mbatha-Rasmussen, MD",
        "specialty": "Nephrology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1876-01-12",
        "display": "January 12, 1876",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in San Francisco as John Griffith Chaney; raised by his mother and his stepfather, John London.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1891",
        "display": "1891 to 1894",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Works from boyhood as an oyster pirate, fish patrolman, seaman and tramp.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1897",
        "display": "1897 to 1898",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Klondike gold rush; comes home with scurvy.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0012",
      "date": {
        "iso": "1900-04-07",
        "display": "April 7, 1900",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Marries; two daughters are born in 1901 and 1902; divorced in 1905, he marries again in November 1905.",
      "claim_ids": [
        "CLM-0016"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1903",
        "display": "1903",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "The Call of the Wild brings international fame; writes 1,000 words a day for the rest of his life.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1905",
        "display": "1905",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Buys the first land of his ranch at Glen Ellen.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1907-04-23",
        "display": "April 23, 1907",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Sails on the Snark; sores, swollen peeling hands and a silvery skin in the South Pacific; gives up the voyage in Australia.",
      "claim_ids": [
        "CLM-0006",
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1913-07",
        "display": "July 1913",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Appendectomy; serious kidney damage found.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1913-08-22",
        "display": "August 22, 1913",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Wolf House burns; John Barleycorn is published the same year.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1914-04",
        "display": "April 1914",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "War correspondent at Vera Cruz; ill with dysentery and rheumatism.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1915-07-22",
        "display": "July 22, 1915",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Returns from five months in Hawaii; sails there again on December 16, 1915.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1916-11-22",
        "display": "November 22, 1916",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at his ranch at 40 of uraemia following renal colic; he had refused his doctors' advice to stop drinking and change his habits. A later story of a morphine overdose or suicide is disputed.",
      "claim_ids": [
        "CLM-0012",
        "CLM-0013",
        "CLM-0014",
        "CLM-0015"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "He was born on January 12, 1876, in San Francisco, and his birth certificate named him John Griffith Chaney. His mother, Flora Wellman, had lived with William Chaney, an astrologer, who left before the birth; she married John London, who adopted and raised the boy.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Jack London was born on January 12, 1876"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "She had her baby with the name John Griffith Chaney on the birth certificate"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "John London, stepfather: married Flora Wellman; adopted and raised Jack"
        },
        {
          "source_id": "SRC-0012",
          "relationship": "context",
          "locator": "roster birth year 1876"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "He grew up poor and worked from boyhood: an oyster pirate at 15, on the fish patrol at 16, an able-bodied seaman at 17, and a tramp crossing America at 18, when he spent a month in jail.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the social history of a man who rose from poverty.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Oyster Pirate, age 15; Fish Patrol, age 16; Able Bodied Seaman, age 17; Tramping across America, age 18; Spent a month in jail"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "He went to the Klondike gold fields in 1897, at 21, and came home with very little after suffering scurvy.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Past nutritional illness; no lasting effect is used in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Jack came home with very little after suffering scurvy and forced to give up"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Seeking gold in the Klondike, age 21"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "He became internationally famous with The Call of the Wild (1903) and The Sea Wolf (1904), completed more than 50 books between 1900 and 1916, was at his peak the highest paid writer in the United States, and pushed to write 1,000 words a day wherever he was.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern writing schedule.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Call of the Wild (1903), The Sea Wolf (1904); more than 50 fiction and non-fiction books; He continued to push to complete 1000 words per day regardless of his location, duties, or health"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "One of the highest paid authors of his time"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "From 1905 he bought land at Glen Ellen in the Sonoma Valley and built up his Beauty Ranch; Wolf House, his nearly finished stone and redwood home, burned on August 22, 1913, a crushing financial loss. The loss left him depressed, but he forced himself back to work.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the setting, the financial pressure and the social history; the word 'depressed' is the park's, not a diagnosis.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Wolf House was burning; a crushing financial blow; The loss of Wolf House left London depressed, but he forced himself to go back to work"
        },
        {
          "source_id": "SRC-0011",
          "relationship": "supports",
          "locator": "London's dream house which was destroyed by fire in 1913"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Buys Hill Ranch in Glen Ellen, first of seven land purchases"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "On the voyage of his yacht Snark through the South Pacific (1907 to 1909), in the Solomon Islands he had sores that a physician in Fiji called yaws and a missionary said were not; his hands swelled and peeled and his toenails thickened, a malady the Australian specialists could not name; he spent five weeks in hospital in Australia, gave up the voyage, and blamed tropical light. He also had a 'silvery skin' that doctors called by old names for leprosy, which cleared without treatment in California.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His own published account, recorded as he gave it; the modern diagnosis of these conditions is not settled (CLM-0007).",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "a physician in Fiji told me they were [yaws], and a missionary in the Solomons told me they were not; my hands have been swelling as with dropsy; The mysterious malady that afflicted my hands was too much for the Australian specialists; I went to Australia to go into hospital, where I spent five weeks; my silvery skin vanished"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Cruising the Pacific, Jack becomes ill with yaws"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "The Snark voyage made it as far as the South Pacific and Australia but was curtailed due to ill health"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Physicians writing since have interpreted his illnesses differently: the 'silvery skin' has been read as psoriasis; one review proposed that mercury used to treat yaws damaged his kidneys and caused a dermatitis of the hands, feet and face; others suggested lupus, gout, and the effects of tobacco, alcohol and diet on his blood pressure and kidneys. None is established.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Retrospective and disputed; none is used as a diagnosis for him. The modern episode's kidney disease has its own synthetic cause.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Bomback and Klemmer: mercury poison from treatment of yaws; severe dermatitis with swelling of hands, feet, cheeks and nose; P. K. Labor: possible lupus as suggested by Denko, polyarticular gout, tobacco, alcohol and hypertension"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "Jack London's chronic interstitial nephritis: a historical differential diagnosis"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "Jack London's mysterious malady"
        },
        {
          "source_id": "SRC-0009",
          "relationship": "supports",
          "locator": "A modern analysis of his mysterious disease"
        },
        {
          "source_id": "SRC-0010",
          "relationship": "context",
          "locator": "The Snark and the Skin: Jack London's Pacific Voyage"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "In John Barleycorn (1913) he wrote of his drinking from the first time he got drunk, at five years old. He held that he was no born alcoholic and had acquired the taste, and described how at the ranch, after writing his thousand words between nine and eleven each morning, he began to take a cocktail before midday dinner and then alone, 'not for the sake of the taste, but for the effect of the drink.'",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His own account of heavy drinking, recorded in his words; it anchors the modern alcohol use disorder but does not make a diagnosis for him.",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "I was five years old the first time I got drunk; I was no hereditary alcoholic; at nine sharp, invariably, I began my writing. By eleven my thousand words were finished; I was beginning to drink alone; for the effect of the drink"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "context",
          "locator": "Among the best known are ... John Barleycorn"
        },
        {
          "source_id": "SRC-0012",
          "relationship": "context",
          "locator": "roster lead: alcohol use disorder"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0009",
      "statement": "In July 1913 he had his appendix removed, and serious kidney damage was found; his physician diagnosed a significant kidney problem at that time.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern chronic kidney disease; the nature of the kidney disease is not documented in the sources read.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "July: appendectomy, serious kidney damage found"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Dr. Porter had diagnosed a significant kidney problem back in July of 1913"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "In 1914 he went to Vera Cruz as a war correspondent in the Mexican Revolution and was ill with dysentery and rheumatism.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Past illnesses; they anchor his joint pain in the modern episode but no diagnosis is made from them.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "April, Jack leaves for Vera Cruz to report on Mexican Revolution; Ill from dysentery and rheumatism"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In 1914 Jack was a war correspondent in Mexico"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "He spent February 24 to July 22, 1915, in Hawaii and sailed there again on December 16, 1915; his health was described that year as declining.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the dates of the modern episode, set at the ranch between the two stays in Hawaii.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "1915 Takes Matsonia to Hawaii 2/24-7/22. Sails to Hawaii 12/16"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "1915: Jack in declining health; Honolulu, March to July"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "His doctors urged him to change his work habits and diet, stop all alcohol and get more exercise, and he refused.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented history; no undated advice is used in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "When London's doctors urged him to change his work habits and his diet, stop all use of alcohol and get more exercise, he refused"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0013",
      "statement": "He died at his ranch on November 22, 1916, at 40. His death certificate, signed by his own physician, gave the cause as uraemia following renal colic; his physicians' bulletin described a gastro-intestinal type of uraemia, with coma, after he was taken ill in the night.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented cause of death; it anchors the modern kidney disease but nothing about his death is used in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "It stated the cause of death was: uraemia following renal colic; This, however, proved to be a gastro-intestinal type of uraemia. He rapidly entered coma and died at 7:45 p.m., November 22, 1916"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "On November 22, 1916, 40-year-old Jack London died of gastrointestinal uremic poisoning"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Jack London dies November 22 of severe uremia"
        },
        {
          "source_id": "SRC-0012",
          "relationship": "context",
          "locator": "roster: renal failure; died at 40 from uremic poisoning"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0014",
      "statement": "Whether morphine contributed to his death is disputed. A story that he took his own life began after his death and was spread by a 1938 biographical novel that described empty morphine vials; his attending physicians denied it, and historians, a pharmacist and physicians have argued against it, noting that he had taken morphine for pain for some time and that failing kidneys would have let a usual dose build up.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Disputed; the record takes neither side, and nothing about suicide or overdose is used in the modern episode. Recorded only as later history.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "The rumor was apparently started shortly after London's death; Doctors Deny Jack London Killed Self; Stone ... two empty vials labeled morphine sulfate and atropine sulfate; with London's use of morphine for possibly as long as three years, he would have developed a tolerance; a dose that normally might have been therapeutic might easily have been rendered toxic by his weakened renal condition"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0016",
      "statement": "He married Bess Maddern in 1900; their daughters Joan and Bess were born in 1901 and 1902, and the marriage ended in divorce in 1905. He married Charmian Kittredge in November 1905.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented family history; no relative has any statement, decision or health fact in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Married April 7, 1900; Daughter Joan is born; October, daughter Bess is born; Divorce final on November 17, 1905; Jack and Charmian marry November 19"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0015",
      "statement": "The roster's leads of depression and probable bipolar disorder are not documented as diagnoses in the sources read.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Not used as diagnoses; the modern episode screens mood with the PHQ-9.",
      "source_links": [
        {
          "source_id": "SRC-0012",
          "relationship": "context",
          "locator": "roster: Depression; probable bipolar"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "context",
          "locator": "The loss of Wolf House left London depressed"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Jack London: A Brief Biography (Education Resources, History on Jack London)",
      "publisher": "Jack London State Historic Park (Jack London Park Partners)",
      "url": "https://jacklondonpark.com/jack-london-biography/",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Historic park biography; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018)",
      "publisher": "Jack London State Historic Park",
      "url": "https://jacklondonpark.com/wp-content/uploads/2023/12/Interpreting-JL-part-1-rev-2018.pdf",
      "source_type": "other",
      "published": "2018-08-01",
      "accessed": "2026-11-05",
      "rights_note": "Historic park docent training material; full text read; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Leal L. The Life of Jack London (docent presentation text and supplemental information, 2017)",
      "publisher": "Jack London State Historic Park",
      "url": "https://jacklondonpark.com/wp-content/uploads/2019/11/1.-LIFE-OF-JL-presentation-text-and-supplemental-information.pdf",
      "source_type": "other",
      "published": "2017-05-19",
      "accessed": "2026-11-05",
      "rights_note": "Historic park training text by the park historian; full text read; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Leal L. The Death of Jack London: Fact and Fiction (2016)",
      "publisher": "Jack London State Historic Park",
      "url": "https://jacklondonpark.com/wp-content/uploads/2019/12/Death-of-Jack-London-Fact-and-Fiction-by-Lou-Leal-2016.pdf",
      "source_type": "other",
      "published": "2016-10-01",
      "accessed": "2026-11-05",
      "rights_note": "Paper by the park historian citing the death certificate, the physicians' bulletin, Huntington Library correspondence and published medical analyses; full text read; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "London J. The Cruise of the Snark (Project Gutenberg eBook #2512)",
      "publisher": "Project Gutenberg",
      "url": "https://www.gutenberg.org/ebooks/2512",
      "source_type": "primary",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Public-domain first-person account; short quotations used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "London J. John Barleycorn (1913) (Project Gutenberg eBook #318)",
      "publisher": "Project Gutenberg",
      "url": "https://www.gutenberg.org/ebooks/318",
      "source_type": "primary",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Public-domain first-person account; short quotations used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Bomback AS, Klemmer PJ. Jack London's \"chronic interstitial nephritis\": a historical differential diagnosis. Pharos Alpha Omega Alpha Honor Med Soc 2008;71(1):26-30 (PMID 18246783)",
      "publisher": "The Pharos",
      "url": "https://pubmed.ncbi.nlm.nih.gov/18246783/",
      "source_type": "scholarly",
      "published": "2008-01-01",
      "accessed": "2026-11-05",
      "rights_note": "PubMed record read; its argument is known from the park historian's summary (SRC-0004)."
    },
    {
      "source_id": "SRC-0008",
      "title": "Bomback AS, Klemmer PJ. Jack London's \"mysterious malady\". Am J Med 2007;120(5):466-467 (PMID 17466662)",
      "publisher": "The American Journal of Medicine",
      "url": "https://pubmed.ncbi.nlm.nih.gov/17466662/",
      "source_type": "scholarly",
      "published": "2007-05-01",
      "accessed": "2026-11-05",
      "rights_note": "PubMed record read; title only."
    },
    {
      "source_id": "SRC-0009",
      "title": "Denko CW. Jack London. A modern analysis of his mysterious disease. J Rheumatol 1993;20(10):1760-1763 (PMID 8295191)",
      "publisher": "The Journal of Rheumatology",
      "url": "https://pubmed.ncbi.nlm.nih.gov/8295191/",
      "source_type": "scholarly",
      "published": "1993-10-01",
      "accessed": "2026-11-05",
      "rights_note": "PubMed record read; its suggestion of lupus is known from the park historian's summary (SRC-0004)."
    },
    {
      "source_id": "SRC-0010",
      "title": "Aronica JC, Norton SA. The Snark and the Skin: Jack London's Pacific Voyage. JAMA Dermatol 2015;151(9):1016 (PMID 26352126)",
      "publisher": "JAMA Dermatology",
      "url": "https://pubmed.ncbi.nlm.nih.gov/26352126/",
      "source_type": "scholarly",
      "published": "2015-09-01",
      "accessed": "2026-11-05",
      "rights_note": "PubMed record read; title only."
    },
    {
      "source_id": "SRC-0011",
      "title": "Jack London State Historic Park",
      "publisher": "California State Parks",
      "url": "https://www.parks.ca.gov/?page_id=478",
      "source_type": "government",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "State park page; facts used with citation."
    },
    {
      "source_id": "SRC-0012",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-08-04",
    "index_age": 39,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Alcohol use disorder with chronic kidney disease and hypertension in a working writer: a 39-year-old novelist who writes a thousand words every morning on his ranch comes in tired, with swollen ankles, and is found to have a blood pressure of 158/98, an eGFR of 43 and albumin in the urine, and to drink heavily. The episode covers the AUDIT, the DSM-5-TR criteria and PEth; liver tests, FIB-4 and elastography; outpatient withdrawal management with a withdrawal-risk score and thiamine; medicine for alcohol use disorder chosen with kidney function in mind (naltrexone, with acamprosate needing a lower dose at his creatinine clearance and avoided below 30 mL/min); CKD staging by KDIGO 2024 with eGFR and urine albumin, the cause (hypertension and two years of daily naproxen, without stones or gout), ultrasound, the kidney failure risk equation and mineral tests; blood pressure under KDIGO 2021 and the 2025 AHA/ACC guideline with an angiotensin receptor blocker at the maximum dose and potassium and creatinine checks; an SGLT2 inhibitor once he is abstinent, because heavy drinking raises the risk of ketoacidosis; analgesic and opioid safety, with no NSAIDs, a lower acetaminophen limit and naltrexone's opioid blockade; the safety assessment and lethal-means counseling; tobacco; vaccinations in kidney and liver disease; and a plan that protects his morning writing hours.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-08-04",
        "purpose": "Establishing care for tiredness and ankle swelling, with high blood pressure and abnormal kidney tests, and heavy drinking found at the visit: kidney, liver and alcohol tests, AUDIT and DSM-5-TR assessment, withdrawal planning, mood and safety, his writing schedule, and a nephrology consultation"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-08-18",
        "purpose": "Two-week review after stopping alcohol and starting losartan, seen the same day by nephrology: kidney staging and cause, ultrasound and elastography, blood pressure target, medicine for alcohol use disorder, and pain relief"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-09-01",
        "purpose": "Same-day sick visit for a right ankle sprain"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-09-15",
        "purpose": "Six-week review: drinking and PEth, blood pressure, potassium and creatinine, urine albumin, liver tests, mood and safety"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-09-29",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-10-13",
        "purpose": "Ten-week review: abstinence, potassium and creatinine after the losartan increase, and the SGLT2 inhibitor"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-27",
        "purpose": "Twelve-week review: kidney function after the SGLT2 inhibitor, urine albumin, liver tests, AUDIT, mood, safety and the plan ahead"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Tiredness, ankle swelling and high blood pressure (158/98 mmHg) with a raised creatinine (1.98 mg/dL, eGFR 43) and albumin in the urine (240 mg/g), found at intake; a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago, by his account; chronicity and cause under evaluation with a nephrology consultation",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R94.4",
            "display": "Abnormal results of kidney function studies",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to the documented kidney damage found in 1913; superseded when the consultation staged chronic kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-08-18"
      },
      {
        "id": "PRB-002",
        "display": "Chronic kidney disease, stage G3b A2 (eGFR 42 to 43, urine albumin 240 mg/g), most likely from hypertension with a contribution from two years of daily naproxen; kidneys of normal size, without stones or obstruction; urine sediment bland; synthetic modern diagnosis linked to his documented kidney disease",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N18.32",
            "display": "Chronic kidney disease, stage 3b",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern diagnosis made at the consultation, anchored to his documented kidney damage and death from uraemia; the cause in the modern episode is synthetic and is not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-08-18"
      },
      {
        "id": "PRB-003",
        "display": "Hypertensive chronic kidney disease, untreated until intake",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I12.9",
            "display": "Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern diagnosis made at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-08-18"
      },
      {
        "id": "PRB-004",
        "display": "Alcohol use disorder, severe (seven DSM-5-TR criteria): a bottle of whisky or more most days for years, a morning drink to steady his hands, failed attempts to cut down, and drinking despite knowing it harms his health; AUDIT 27; PEth 410 ng/mL",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F10.20",
            "display": "Alcohol dependence, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern diagnosis anchored to his own published account of heavy drinking; the criteria, scores and amounts are synthetic and are not a claim about his real drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-005",
        "display": "Alcohol-associated fatty liver without advanced fibrosis (liver stiffness 7.2 kPa; steatosis on ultrasound); FIB-4 2.28 at intake",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K70.0",
            "display": "Alcoholic fatty liver",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic finding of the ultrasound and elastography at the consultation; not a claim about his real liver.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-08-18"
      },
      {
        "id": "PRB-006",
        "display": "Daily self-directed naproxen for knee and back pain for about two years, stopped at intake; acetaminophen in its place",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z79.1",
            "display": "Long term (current) use of non-steroidal anti-inflammatories (NSAID)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic medication history; the joint pain is anchored to the documented rheumatism of 1914, which is not given a diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-08-18"
      },
      {
        "id": "PRB-007",
        "display": "Cigarette smoking, about ten a day; not ready to stop while he stops drinking",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F17.210",
            "display": "Nicotine dependence, cigarettes, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic tobacco use; a physician-author's suggestion of heavy tobacco use is recorded only as a retrospective claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-008",
        "display": "Right ankle sprain (lateral ligaments, moderate), from stepping into a burrow while walking the pasture; Ottawa ankle rules negative; healed in about four weeks",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "S93.401A",
            "display": "Sprain of unspecified ligament of right ankle, initial encounter",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic acute injury; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-09-01",
        "abatement_date": "2026-10-13"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Naproxen 500 mg oral tablet twice daily, bought over the counter at full strength and taken most days for about two years for knee and back pain; stopped at intake",
        "status": "stopped",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198014",
            "display": "naproxen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 500,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet by mouth twice a day, self-directed"
        },
        "start_date": "2024-08-01",
        "end_date": "2026-08-04",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic self-directed anti-inflammatory use that contributes to the kidney disease; stopped at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Losartan 50 mg oral tablet once daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979492",
            "display": "losartan potassium 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 50,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth every morning"
        },
        "start_date": "2026-08-04",
        "end_date": "2026-09-15",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic angiotensin receptor blocker started at intake for high blood pressure with albumin in the urine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Losartan 100 mg oral tablet once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979480",
            "display": "losartan potassium 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 100,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth every morning"
        },
        "start_date": "2026-09-15",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic dose increase to the maximum dose at six weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Chlordiazepoxide 25 mg oral capsule, fixed five-day taper for alcohol withdrawal (four capsules on day 1, three on day 2, two on day 3, one on days 4 and 5), dispensed for five days only, with a daily telephone check",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "905495",
            "display": "chlordiazepoxide hydrochloride 25 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 25,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "Up to one capsule four times a day on day 1, tapering to one a day by day 4; stop after day 5; no alcohol or driving"
        },
        "start_date": "2026-08-04",
        "end_date": "2026-08-08",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic outpatient withdrawal management for a man with a low withdrawal-risk score and no cirrhosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Thiamine 100 mg oral tablet once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313323",
            "display": "thiamine 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 100,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-08-04",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic thiamine for a man with heavy drinking and an irregular diet.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for pain, no more than 2,000 mg in a day, in place of naproxen",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 500,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "One to two tablets by mouth every six hours as needed; no more than four tablets a day"
        },
        "start_date": "2026-08-04",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safer pain relief in kidney disease, with a lower daily limit because of recent heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "as_needed": true
      },
      {
        "id": "MED-007",
        "display": "Naltrexone 50 mg oral tablet once daily, with a wallet card warning that it blocks opioid pain medicines",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1483744",
            "display": "naltrexone hydrochloride 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 50,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth every morning"
        },
        "start_date": "2026-08-18",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic medicine for alcohol use disorder chosen at the consultation: no kidney dose change needed at his eGFR, liver tests acceptable, no opioid use.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199362",
            "display": "cholecalciferol 0.025 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 25,
          "unit": "ug"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-09-15",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic supplement for vitamin D insufficiency in chronic kidney disease, found at six weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Dapagliflozin 10 mg oral tablet once daily, held on any day he cannot eat or drink normally, and before surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1488569",
            "display": "dapagliflozin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 10,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth every morning; sick-day rules in writing"
        },
        "start_date": "2026-10-13",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic SGLT2 inhibitor started at ten weeks, six weeks after his one lapse, as the consultation advised.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Diclofenac 1% gel, 4 g rubbed into the outer right ankle four times a day for up to seven days, in place of any oral anti-inflammatory medicine",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "855633",
            "display": "diclofenac sodium 0.01 MG/MG Topical Gel",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 4,
          "unit": "g"
        },
        "route": "topical",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "Apply 4 g to the ankle four times a day for up to seven days"
        },
        "start_date": "2026-09-01",
        "end_date": "2026-09-08",
        "indication_problem_ids": [
          "PRB-008"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic short course of a topical anti-inflammatory to a small area, which gives far lower blood levels than tablets; chosen with the kidney disease in mind.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic basic metabolic panel at intake: creatinine 1.98 mg/dL, eGFR 43 (CKD-EPI 2021). Not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic basic metabolic panel at intake: creatinine 1.98 mg/dL, eGFR 43 (CKD-EPI 2021). Not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V1",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 22,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic basic metabolic panel at intake: creatinine 1.98 mg/dL, eGFR 43 (CKD-EPI 2021). Not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-BUN-V1",
        "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
        "label": "Urea nitrogen",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 28,
        "unit": "mg/dL",
        "reference_range": {
          "low": 7,
          "high": 20
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3094-0",
            "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic basic metabolic panel at intake: creatinine 1.98 mg/dL, eGFR 43 (CKD-EPI 2021). Not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 1.98,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic basic metabolic panel at intake: creatinine 1.98 mg/dL, eGFR 43 (CKD-EPI 2021). Not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic basic metabolic panel at intake: creatinine 1.98 mg/dL, eGFR 43 (CKD-EPI 2021). Not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 43,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "45 to 59 is G3a; 30 to 44 is G3b"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic basic metabolic panel at intake: creatinine 1.98 mg/dL, eGFR 43 (CKD-EPI 2021). Not a claim about his real kidneys.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 240,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g A1; 30 to 300 A2; above 300 A3"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio at intake: moderately increased (A2).",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-URATE-V1",
        "display": "Urate [Mass/volume] in Serum or Plasma",
        "label": "Uric acid",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 8.4,
        "unit": "mg/dL",
        "reference_range": {
          "low": 4.0,
          "high": 8.0
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3084-1",
            "display": "Urate [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic uric acid and mineral tests at intake: uric acid and PTH mildly high.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V1",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 9.2,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic uric acid and mineral tests at intake: uric acid and PTH mildly high.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHOS-V1",
        "display": "Phosphate [Mass/volume] in Serum or Plasma",
        "label": "Phosphate",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 3.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 2.5,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2777-1",
            "display": "Phosphate [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic uric acid and mineral tests at intake: uric acid and PTH mildly high.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PTH-V1",
        "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
        "label": "Parathyroid hormone, intact",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 74,
        "unit": "pg/mL",
        "reference_range": {
          "low": 15,
          "high": 65
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2731-8",
            "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic uric acid and mineral tests at intake: uric acid and PTH mildly high.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 13.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.0,
          "high": 17.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic blood count at intake: large red cells and low-normal platelets, as heavy drinking causes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V1",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 101,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic blood count at intake: large red cells and low-normal platelets, as heavy drinking causes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 182,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic blood count at intake: large red cells and low-normal platelets, as heavy drinking causes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 68,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at intake: AST above ALT and a high GGT, the pattern of heavy drinking; albumin, bilirubin and INR normal. FIB-4 2.28.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 41,
        "unit": "U/L",
        "reference_range": {
          "low": 9,
          "high": 46
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at intake: AST above ALT and a high GGT, the pattern of heavy drinking; albumin, bilirubin and INR normal. FIB-4 2.28.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V1",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 186,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at intake: AST above ALT and a high GGT, the pattern of heavy drinking; albumin, bilirubin and INR normal. FIB-4 2.28.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 4.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at intake: AST above ALT and a high GGT, the pattern of heavy drinking; albumin, bilirubin and INR normal. FIB-4 2.28.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 0.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.2,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at intake: AST above ALT and a high GGT, the pattern of heavy drinking; albumin, bilirubin and INR normal. FIB-4 2.28.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V1",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 1.0,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.9,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at intake: AST above ALT and a high GGT, the pattern of heavy drinking; albumin, bilirubin and INR normal. FIB-4 2.28.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V1",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "PEth (alcohol marker)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 410,
        "unit": "ng/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PEth at intake, reflecting the past two to four weeks: above 200 ng/mL, heavy drinking. Explained to him and done with his consent. Not a claim about his real drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "HbA1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 5.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic HbA1c and lipid panel at intake, once at the diagnosis of kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 214,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic HbA1c and lipid panel at intake, once at the diagnosis of kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 58,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic HbA1c and lipid panel at intake, once at the diagnosis of kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol (calculated)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 128,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic HbA1c and lipid panel at intake, once at the diagnosis of kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 140,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic HbA1c and lipid panel at intake, once at the diagnosis of kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDIT-V1",
        "display": "Total score [AUDIT]",
        "label": "AUDIT",
        "status": "final",
        "effective_date": "2026-08-04",
        "value": 27,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75624-7",
            "display": "Total score [AUDIT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic AUDIT: 20 or more suggests alcohol dependence. Not a claim about his real drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-04",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9: mild symptoms, mostly poor sleep, fatigue and irritability; item 9 scored 0. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V1",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-08-04",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7: mild anxiety, mostly about money and the work.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V2",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 4.9,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine two weeks after starting losartan: creatinine up 3 percent, potassium normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 2.04,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine two weeks after starting losartan: creatinine up 3 percent, potassium normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 42,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "45 to 59 is G3a; 30 to 44 is G3b"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine two weeks after starting losartan: creatinine up 3 percent, potassium normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V2",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 49,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests after twelve days without alcohol, before naltrexone: falling.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V2",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 36,
        "unit": "U/L",
        "reference_range": {
          "low": 9,
          "high": 46
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests after twelve days without alcohol, before naltrexone: falling.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V2",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 141,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests after twelve days without alcohol, before naltrexone: falling.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V3",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function at six weeks on losartan 50 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V3",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 4.8,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function at six weeks on losartan 50 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V3",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 23,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function at six weeks on losartan 50 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 1.96,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function at six weeks on losartan 50 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 44,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "45 to 59 is G3a; 30 to 44 is G3b"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function at six weeks on losartan 50 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V3",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 128,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g A1; 30 to 300 A2; above 300 A3"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic urine albumin at six weeks: down by about half on losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 34,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at six weeks, four weeks into naltrexone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 29,
        "unit": "U/L",
        "reference_range": {
          "low": 9,
          "high": 46
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at six weeks, four weeks into naltrexone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V3",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 82,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests at six weeks, four weeks into naltrexone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V3",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "PEth (alcohol marker)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 36,
        "unit": "ng/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PEth at six weeks: much lower, consistent with the single evening of drinking he reported two weeks earlier.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V3",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-15",
        "value": 24,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100,
          "text": "Below 20 ng/mL deficient; 20 to 29 insufficient"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D, the baseline missed at intake: insufficient.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-09-15",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at six weeks; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-29",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at the preventive visit; negative.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-13",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine four weeks after raising losartan to 100 mg: potassium at the upper end of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-13",
        "value": 5.0,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine four weeks after raising losartan to 100 mg: potassium at the upper end of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V4",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-13",
        "value": 23,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine four weeks after raising losartan to 100 mg: potassium at the upper end of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-13",
        "value": 1.95,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine four weeks after raising losartan to 100 mg: potassium at the upper end of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-13",
        "value": 44,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "45 to 59 is G3a; 30 to 44 is G3b"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic potassium and creatinine four weeks after raising losartan to 100 mg: potassium at the upper end of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V4",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "PEth (alcohol marker)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-13",
        "value": 8,
        "unit": "ng/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PEth at ten weeks: below 20 ng/mL, consistent with abstinence, as he reports.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function two weeks after starting dapagliflozin: the expected small fall in eGFR (about 9 percent), well within the 30 percent that is accepted.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 4.7,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function two weeks after starting dapagliflozin: the expected small fall in eGFR (about 9 percent), well within the 30 percent that is accepted.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V5",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 23,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function two weeks after starting dapagliflozin: the expected small fall in eGFR (about 9 percent), well within the 30 percent that is accepted.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-BUN-V5",
        "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
        "label": "Urea nitrogen",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 24,
        "unit": "mg/dL",
        "reference_range": {
          "low": 7,
          "high": 20
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3094-0",
            "display": "Urea nitrogen [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function two weeks after starting dapagliflozin: the expected small fall in eGFR (about 9 percent), well within the 30 percent that is accepted.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 2.13,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function two weeks after starting dapagliflozin: the expected small fall in eGFR (about 9 percent), well within the 30 percent that is accepted.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 40,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "45 to 59 is G3a; 30 to 44 is G3b"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney function two weeks after starting dapagliflozin: the expected small fall in eGFR (about 9 percent), well within the 30 percent that is accepted.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V5",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 96,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g A1; 30 to 300 A2; above 300 A3"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic urine albumin at twelve weeks on losartan 100 mg and two weeks of dapagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 29,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests and MCV at twelve weeks: normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 9,
          "high": 46
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests and MCV at twelve weeks: normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V5",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 54,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests and MCV at twelve weeks: normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V5",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 96,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver tests and MCV at twelve weeks: normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V5",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "PEth (alcohol marker)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 6,
        "unit": "ng/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PEth at twelve weeks: consistent with abstinence.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDIT-V5",
        "display": "Total score [AUDIT]",
        "label": "AUDIT",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75624-7",
            "display": "Total score [AUDIT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic AUDIT at twelve weeks, answered for the past three months, which include one evening of drinking and the end of the withdrawal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at twelve weeks; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V5",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7 at twelve weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Ultrasound of the abdomen and kidneys: right kidney 10.8 cm and left 11.0 cm with increased cortical echogenicity and preserved cortical thickness, no stones, no hydronephrosis, no cysts; bright liver consistent with steatosis, smooth outline, normal spleen, no ascites",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "438416007",
            "display": "Ultrasonography of abdomen and urinary system",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-18",
          "end": "2026-08-18"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic ultrasound for new kidney disease and abnormal liver tests.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Vibration-controlled transient elastography of the liver: median liver stiffness 7.2 kPa (interquartile range under 30 percent), controlled attenuation parameter 312 dB/m; advanced fibrosis unlikely",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "441491005",
            "display": "Ultrasound elastography of liver",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-18",
          "end": "2026-08-18"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic elastography for an indeterminate FIB-4 (2.28).",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-29",
          "end": "2026-09-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, inactivated, trivalent, preservative-free, for this season",
        "status": "completed",
        "date": "2026-09-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination; chronic kidney and liver disease and heavy alcohol use raise his risk.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine (PCV20), single dose",
        "status": "completed",
        "date": "2026-09-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination, recommended at 19 to 49 for chronic kidney disease, alcohol use disorder and cigarette smoking.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis B vaccine (HepB-CpG), first of two doses",
        "status": "completed",
        "date": "2026-09-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination: recommended for all adults 19 to 59, and important in kidney and liver disease; serology negative.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis A vaccine, adult, first of two doses",
        "status": "completed",
        "date": "2026-09-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "52",
            "display": "Hep A, adult",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis A vaccination for chronic liver disease; second dose in six months.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (HepB-CpG), second of two doses",
        "status": "completed",
        "date": "2026-10-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second hepatitis B dose four weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Scurvy in the gold fields in his early twenties; recovered",
        "historical_date": {
          "iso": "1897",
          "display": "1897 to 1898",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Skin sores, swollen and peeling hands and feet, and a silvery skin during a long Pacific voyage, with five weeks in hospital; the hands recovered and the skin cleared without treatment; the diagnoses were never settled",
        "historical_date": {
          "iso": "1908",
          "display": "1907 to 1909",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "R",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Appendectomy, at which kidney damage was found",
        "historical_date": {
          "iso": "1913-07",
          "display": "July 1913",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "PMH-004",
        "display": "Dysentery and joint pain (described as rheumatism) while working abroad",
        "historical_date": {
          "iso": "1914",
          "display": "1914",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing care for tiredness and ankle swelling, with high blood pressure and abnormal kidney tests, and heavy drinking found at the visit: kidney, liver and alcohol tests, AUDIT and DSM-5-TR assessment, withdrawal planning, mood and safety, his writing schedule, and a nephrology consultation",
        "status": "finished",
        "date": "2026-08-04",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review after stopping alcohol and starting losartan, seen the same day by nephrology: kidney staging and cause, ultrasound and elastography, blood pressure target, medicine for alcohol use disorder, and pain relief",
        "status": "finished",
        "date": "2026-08-18",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Two-week review after stopping alcohol and starting losartan, seen the same day by nephrology",
          "hpi": {
            "narrative": "Mr. London stopped drinking on the morning after his intake visit and took the five-day chlordiazepoxide taper as prescribed, with a daily telephone check from the nurse. The first three days brought sweats, a tremor and poor sleep, at worst a CIWA-Ar of 11 on the second day, with no hallucinations or seizures; by the fifth day the tremor had gone, and he has had no alcohol since. He missed two mornings of writing and has written his thousand words every other day. He has taken losartan 50 mg daily without dizziness and stopped naproxen; acetaminophen eases his knee. His ankles are less swollen. He has seen the clinic's addiction counselor once. The insurance examination report has arrived, confirming a creatinine of 1.7 mg/dL about fourteen months ago. Ultrasound and liver elastography were done this morning. He sees Dr. Mbatha-Rasmussen of nephrology this afternoon.",
            "elements": [
              {
                "label": "Alcohol",
                "value": "None for twelve days; withdrawal completed, peak CIWA-Ar 11"
              },
              {
                "label": "Losartan",
                "value": "50 mg daily for two weeks; no side effects"
              },
              {
                "label": "Potassium and creatinine",
                "value": "4.9 mmol/L; 2.04 mg/dL (eGFR 42), up 3 percent"
              },
              {
                "label": "Earlier creatinine",
                "value": "1.7 mg/dL about fourteen months ago"
              },
              {
                "label": "Ultrasound",
                "value": "Kidneys normal in size, echogenic, no stones or obstruction; fatty liver"
              },
              {
                "label": "Elastography",
                "value": "Liver stiffness 7.2 kPa"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired, but sleeping better than last week"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Ankle swelling less"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No flank pain or blood in the urine"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "Tremor gone; no confusion"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Restless and irritable; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 146/92, pulse 84; weight 83.6 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; trace ankle edema"
            },
            {
              "system": "Neurological",
              "finding": "No tremor; gait normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm and engaged; no thoughts of suicide"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "Dr. Mbatha-Rasmussen confirms chronic kidney disease: a creatinine of 1.7 mg/dL fourteen months ago and 1.98 now, eGFR 42 to 43 and urine albumin 240 mg/g. Normal-sized echogenic kidneys without stones or obstruction and a bland urine sediment point to hypertensive kidney disease with a contribution from two years of daily naproxen; a biopsy is not needed now. Five-year kidney failure risk about 5 percent. Hepatitis B, hepatitis C and HIV serology drawn today",
              "plan": [
                "Continue losartan; raise to 100 mg at six weeks if potassium allows",
                "Dapagliflozin once he has been abstinent for some weeks and is eating regularly",
                "25-hydroxyvitamin D, missed at intake, with the next blood test",
                "Nephrology review in three months"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertensive chronic kidney disease",
              "assessment": "146/92, from 158/98. Target below 120 systolic by standardized measurement if tolerated",
              "plan": [
                "Less salt; home readings"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Alcohol use disorder, severe",
              "assessment": "Withdrawal completed safely; twelve days without alcohol. With Dr. Mbatha-Rasmussen he chose naltrexone, which needs no dose change at his kidney function, over acamprosate, which would need a lower dose at his creatinine clearance of about 58 mL/min and three doses a day. Liver tests are falling and well under three times normal; no opioid use. Safety reviewed: no thoughts of suicide or self-harm; firearms locked; 988 card carried",
              "plan": [
                "Naltrexone 50 mg every morning from today, with a wallet card",
                "Counseling weekly; continue thiamine"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Alcohol-associated fatty liver",
              "assessment": "FIB-4 2.28 was indeterminate; liver stiffness 7.2 kPa makes advanced fibrosis unlikely, though stiffness can read high soon after heavy drinking. Abstinence is the treatment",
              "plan": [
                "Liver tests at six weeks"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Naproxen use",
              "assessment": "Stopped; acetaminophen is controlling the knee pain",
              "plan": [
                "No oral anti-inflammatory medicines"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Standardized office blood pressure (five minutes' rest, validated device, average of readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "146/92 mmHg",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine after starting or changing losartan or an SGLT2 inhibitor",
              "cadence": "Two to four weeks after each start or change",
              "status": "completed_today",
              "detail": "Two weeks after losartan 50 mg: potassium 4.9 mmol/L; creatinine 2.04 mg/dL, up 3 percent; eGFR 42",
              "observation_ids": [
                "OBS-K-V2",
                "OBS-CR-V2",
                "OBS-EGFR-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine with eGFR and urine albumin-to-creatinine ratio",
              "cadence": "G3b A2: twice a year, and at each medicine check",
              "status": "up_to_date",
              "detail": "eGFR 43 and urine albumin 240 mg/g at intake; with a creatinine of 1.7 mg/dL fourteen months ago, chronic for more than three months",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urinalysis with microscopy",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Bland at intake: 2+ protein, no blood, casts or crystals",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Kidney ultrasound",
              "cadence": "At diagnosis of chronic kidney disease of unclear cause",
              "status": "completed_today",
              "detail": "Kidneys 10.8 and 11.0 cm, echogenic, no stones or obstruction",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium, phosphate and PTH",
              "cadence": "G3a to G3b: every six to twelve months",
              "status": "up_to_date",
              "detail": "Calcium 9.2 and phosphate 3.8 mg/dL; PTH 74 pg/mL, mildly high, at intake",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "At baseline",
              "status": "deferred",
              "detail": "The baseline 25-hydroxyvitamin D was left off the intake order and was not drawn. PTH is only mildly high and calcium and phosphate are normal, so no harm is likely from a delay of a few weeks. Corrective action: added to the next blood draw, and the clinic's new-CKD order set checked",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "G3: at least yearly",
              "status": "up_to_date",
              "detail": "13.6 g/dL at intake",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "Once at diagnosis",
              "status": "up_to_date",
              "detail": "LDL 128 mg/dL at intake; statin not indicated at 39",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Kidney failure risk equation (2- and 5-year)",
              "cadence": "Yearly in G3 to G5, and before referral decisions",
              "status": "completed_today",
              "detail": "Five-year risk about 5 percent; two-year about 1.5 percent",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication reconciliation: no NSAIDs, kidney dosing, contrast safety",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Naproxen stopped; acetaminophen within 2,000 mg a day",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Lifestyle: sodium below 2 g a day, activity, diet, weight",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sodium below 2 g a day explained; protein about 0.8 g/kg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking since the last visit (self-report)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None for twelve days",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Withdrawal monitoring (CIWA-Ar) and thiamine",
              "cadence": "During withdrawal; thiamine throughout early recovery",
              "status": "completed_today",
              "detail": "Withdrawal completed with a peak CIWA-Ar of 11 on day 2; no seizures or hallucinations; thiamine continued",
              "guideline_ids": [
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT) on naltrexone",
              "cadence": "At baseline, at four to six weeks, then every few months",
              "status": "completed_today",
              "detail": "Before naltrexone: AST 49, ALT 36, GGT 141 U/L, falling",
              "observation_ids": [
                "OBS-AST-V2",
                "OBS-ALT-V2",
                "OBS-GGT-V2"
              ],
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone safety: opioid use, nausea, wallet card",
              "cadence": "At the start and every visit",
              "status": "completed_today",
              "detail": "No opioid use; wallet card given; started today",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver fibrosis: FIB-4, then elastography if indeterminate",
              "cadence": "At diagnosis of alcohol-associated liver disease",
              "status": "completed_today",
              "detail": "FIB-4 2.28 at intake; liver stiffness 7.2 kPa today",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "referral",
              "measure": "Nephrology consultation",
              "cadence": "At diagnosis, with a five-year kidney failure risk of 3 to 5 percent or more",
              "status": "completed_today",
              "detail": "Seen by Dr. Mbatha-Rasmussen today",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Addiction-focused counseling and mutual help",
              "cadence": "Weekly in early recovery",
              "status": "completed_today",
              "detail": "First session done; weekly from now",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, firearms storage, safety plan and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; firearms locked with the ammunition apart; 988 card carried",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use and readiness to stop",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "About ten a day; not ready to stop",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            }
          ],
          "follow_up": "Six-week review with potassium, creatinine, urine albumin, liver tests, PEth and vitamin D. Counseling weekly. The clinic or 988 at any hour",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-APA-AUD-2018",
            "GL-SUD-2021",
            "GL-ASAM-AWM-2020",
            "GL-AASLD-NIT-2025",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Six-week review: drinking and PEth, blood pressure, potassium and creatinine, urine albumin, liver tests, mood and safety",
        "status": "finished",
        "date": "2026-09-15",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Six-week review",
          "hpi": {
            "narrative": "Mr. London has not had a drink since the evening two weeks ago when he sprained his ankle and drank two large whiskies for the pain; he talked that evening through with his counselor and has set a plan for pain and late afternoons. He takes naltrexone every morning without nausea. The ankle is much better with the brace and he has stopped the gel. He writes every morning and swims at the hour he used to take his first drink. He takes losartan 50 mg without dizziness; his home readings average 136/86. He is sleeping six hours. He has had no opioid or anti-inflammatory medicine. His hepatitis B, hepatitis C and HIV tests were negative.",
            "elements": [
              {
                "label": "Alcohol",
                "value": "One evening two weeks ago; none since"
              },
              {
                "label": "PEth",
                "value": "36 ng/mL, from 410"
              },
              {
                "label": "Kidneys",
                "value": "Creatinine 1.96 mg/dL, eGFR 44; potassium 4.8; urine albumin 128 mg/g"
              },
              {
                "label": "Liver tests",
                "value": "AST 34, ALT 29, GGT 82 U/L"
              },
              {
                "label": "Vitamin D",
                "value": "24 ng/mL"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 5, item 9 scored 0"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy better in the afternoons"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No ankle swelling"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Right ankle slightly sore after a long walk"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steadier; cravings in the late afternoon, less strong; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 138/86, pulse 78; weight 82.6 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no edema"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Right ankle: slight swelling, mild tenderness over the anterior talofibular ligament; walks normally"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "Stable: creatinine 1.96 mg/dL, eGFR 44; potassium 4.8 mmol/L. Urine albumin down from 240 to 128 mg/g on losartan 50 mg. 25-hydroxyvitamin D 24 ng/mL, insufficient, with a mildly high PTH",
              "plan": [
                "Losartan 100 mg daily from today; potassium and creatinine in four weeks",
                "Vitamin D3 25 micrograms daily"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertensive chronic kidney disease",
              "assessment": "138/86, above target",
              "plan": [
                "Losartan to the maximum dose"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Alcohol use disorder, severe, in early recovery",
              "assessment": "PEth 36 ng/mL fits the single evening of drinking he reported; liver tests near normal on naltrexone. Safety reviewed: no thoughts of suicide or self-harm, firearms locked, 988 card carried",
              "plan": [
                "Continue naltrexone and weekly counseling",
                "PEth at ten weeks"
              ]
            },
            {
              "problem_id": "PRB-008",
              "display": "Right ankle sprain",
              "assessment": "Healing well",
              "plan": [
                "Ankle exercises; brace for riding until fully healed"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Standardized office blood pressure (five minutes' rest, validated device, average of readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "138/86 mmHg; home average 136/86",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine after starting or changing losartan or an SGLT2 inhibitor",
              "cadence": "Two to four weeks after each start or change",
              "status": "completed_today",
              "detail": "Six weeks on losartan 50 mg: potassium 4.8 mmol/L, creatinine 1.96 mg/dL; recheck four weeks after today's increase",
              "observation_ids": [
                "OBS-K-V3",
                "OBS-CR-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine with eGFR and urine albumin-to-creatinine ratio",
              "cadence": "G3b A2: twice a year, and at each medicine check",
              "status": "completed_today",
              "detail": "eGFR 44; urine albumin 128 mg/g, down by about half",
              "observation_ids": [
                "OBS-EGFR-V3",
                "OBS-UACR-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Electrolytes and bicarbonate",
              "cadence": "With each kidney test",
              "status": "completed_today",
              "detail": "Sodium 140; bicarbonate 23 mmol/L",
              "observation_ids": [
                "OBS-NA-V3",
                "OBS-CO2-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "24 ng/mL, insufficient; the test deferred from intake; vitamin D3 started",
              "observation_ids": [
                "OBS-VITD-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication reconciliation: no NSAIDs, kidney dosing, contrast safety",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No oral NSAIDs; topical diclofenac for the sprain finished; acetaminophen within limits",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Lifestyle: sodium below 2 g a day, activity, diet, weight",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Less salt; swimming most days",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking since the last visit (self-report)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "One evening two weeks ago; none since",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "PEth",
              "cadence": "At baseline and every four to six weeks in early recovery",
              "status": "completed_today",
              "detail": "36 ng/mL, from 410",
              "observation_ids": [
                "OBS-PETH-V3"
              ],
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT) on naltrexone",
              "cadence": "At baseline, at four to six weeks, then every few months",
              "status": "completed_today",
              "detail": "AST 34, ALT 29, GGT 82 U/L at four weeks of naltrexone",
              "observation_ids": [
                "OBS-AST-V3",
                "OBS-ALT-V3",
                "OBS-GGT-V3"
              ],
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021",
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone safety: opioid use, nausea, wallet card",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No nausea; no opioid; he declined to ask for one for the sprain",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Addiction-focused counseling and mutual help",
              "cadence": "Weekly in early recovery",
              "status": "completed_today",
              "detail": "Four sessions; a plan for pain and late afternoons",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9 and GAD-7",
              "cadence": "At intake and at follow-up",
              "status": "completed_today",
              "detail": "PHQ-9 5, from 9; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, firearms storage, safety plan and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; firearms locked; 988 card carried",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use and readiness to stop",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "About ten a day; will discuss at the preventive visit",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            }
          ],
          "follow_up": "Preventive visit in two weeks. Ten-week review with potassium, creatinine and PEth. Counseling weekly. The clinic or 988 at any hour",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-AHA-HTN-2025",
            "GL-APA-AUD-2018",
            "GL-SUD-2021",
            "GL-AASLD-ALD-2019",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Ten-week review: abstinence, potassium and creatinine after the losartan increase, and the SGLT2 inhibitor",
        "status": "finished",
        "date": "2026-10-13",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Ten-week review",
          "hpi": {
            "narrative": "Mr. London has had no alcohol for six weeks, since the evening of the ankle sprain. He takes naltrexone and losartan 100 mg every morning; he has had no dizziness. His home readings average 124/78. He eats two meals a day now, and has not missed a meal or been unwell for weeks. The ankle has healed and he is riding again. He writes every morning and has finished a long story. He has kept up weekly counseling.",
            "elements": [
              {
                "label": "Alcohol",
                "value": "None for six weeks; PEth 8 ng/mL"
              },
              {
                "label": "Potassium and creatinine",
                "value": "5.0 mmol/L; 1.95 mg/dL (eGFR 44) four weeks after losartan 100 mg"
              },
              {
                "label": "Home readings",
                "value": "Average 124/78 mmHg"
              },
              {
                "label": "Ankle",
                "value": "Healed"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; eating regularly"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No dizziness or ankle swelling"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary or genital symptoms"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; cravings rare; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 126/80, pulse 72; weight 81.4 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no edema"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Right ankle normal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "Stable on losartan 100 mg: creatinine 1.95 mg/dL, eGFR 44, potassium 5.0 mmol/L at the upper end of normal. With six weeks of abstinence, regular meals and no diabetes, the risk of ketoacidosis from an SGLT2 inhibitor is now low, and KDIGO recommends one for his eGFR and albuminuria; it also lowers potassium and uric acid a little",
              "plan": [
                "Dapagliflozin 10 mg every morning from today",
                "Sick-day rules in writing: hold dapagliflozin on any day he cannot eat or drink normally, with vomiting or diarrhea, before surgery, or if he drinks heavily again",
                "Potassium and creatinine in two weeks; an early fall in eGFR of up to 30 percent is expected and accepted"
              ]
            },
            {
              "problem_id": "PRB-008",
              "display": "Right ankle sprain",
              "assessment": "Healed",
              "plan": [
                "No further treatment"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Alcohol use disorder, severe, in early recovery",
              "assessment": "PEth 8 ng/mL confirms abstinence. Safety reviewed: no thoughts of suicide or self-harm, firearms locked, 988 card carried",
              "plan": [
                "Continue naltrexone and counseling"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Standardized office blood pressure (five minutes' rest, validated device, average of readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "126/80 mmHg; home average 124/78",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine after starting or changing losartan or an SGLT2 inhibitor",
              "cadence": "Two to four weeks after each start or change",
              "status": "completed_today",
              "detail": "Four weeks after losartan 100 mg: potassium 5.0 mmol/L, creatinine 1.95 mg/dL; dapagliflozin started today, recheck in two weeks",
              "observation_ids": [
                "OBS-K-V4",
                "OBS-CR-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine with eGFR and urine albumin-to-creatinine ratio",
              "cadence": "G3b A2: twice a year, and at each medicine check",
              "status": "completed_today",
              "detail": "eGFR 44; urine albumin due at twelve weeks",
              "observation_ids": [
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Electrolytes and bicarbonate",
              "cadence": "With each kidney test",
              "status": "completed_today",
              "detail": "Sodium 139; bicarbonate 23 mmol/L",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-CO2-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "SGLT2 inhibitor safety: sick-day rules, ketoacidosis, genital infection, volume",
              "cadence": "At the start and every visit",
              "status": "completed_today",
              "detail": "Started today after six weeks of abstinence and regular meals; sick-day rules in writing; genital hygiene explained",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication reconciliation: no NSAIDs, kidney dosing, contrast safety",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No NSAIDs; dapagliflozin added",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Lifestyle: sodium below 2 g a day, activity, diet, weight",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Riding and swimming; less salt",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking since the last visit (self-report)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None for six weeks",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "PEth",
              "cadence": "At baseline and every four to six weeks in early recovery",
              "status": "completed_today",
              "detail": "8 ng/mL: abstinence",
              "observation_ids": [
                "OBS-PETH-V4"
              ],
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT) on naltrexone",
              "cadence": "At baseline, at four to six weeks, then every few months",
              "status": "up_to_date",
              "detail": "Normal-range at six weeks; next at twelve weeks",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone safety: opioid use, nausea, wallet card",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No nausea; no opioid",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Addiction-focused counseling and mutual help",
              "cadence": "Weekly in early recovery",
              "status": "completed_today",
              "detail": "Weekly sessions kept",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, firearms storage, safety plan and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; firearms locked; 988 card carried",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use and readiness to stop",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "About ten a day; thinking about a quit date",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            }
          ],
          "follow_up": "Twelve-week review in two weeks with potassium, creatinine, urine albumin, liver tests, PEth, AUDIT, PHQ-9 and GAD-7. Counseling weekly. The clinic or 988 at any hour",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-AHA-HTN-2025",
            "GL-APA-AUD-2018",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Twelve-week review: kidney function after the SGLT2 inhibitor, urine albumin, liver tests, AUDIT, mood, safety and the plan ahead",
        "status": "finished",
        "date": "2026-10-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Twelve-week review",
          "hpi": {
            "narrative": "Mr. London has had no alcohol for eight weeks. He has taken dapagliflozin for two weeks with a little more passing of urine and no dizziness, genital symptoms or illness, and has not needed the sick-day rules. He takes losartan 100 mg, naltrexone, thiamine and vitamin D3 every morning. His home readings average 120/76. He writes every morning and has started a new novel; he swims or rides in the late morning. He would like to stop smoking in the new year. He asks what the next months hold for his kidneys.",
            "elements": [
              {
                "label": "Alcohol",
                "value": "None for eight weeks; PEth 6 ng/mL; AUDIT 9 for the past three months"
              },
              {
                "label": "Kidneys",
                "value": "Creatinine 2.13 mg/dL, eGFR 40 after two weeks of dapagliflozin; potassium 4.7; urine albumin 96 mg/g"
              },
              {
                "label": "Liver tests",
                "value": "AST 29, ALT 26, GGT 54 U/L; MCV 96 fL"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 4, item 9 scored 0; GAD-7 4"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; weight down 3.3 kg since intake"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Passing a little more urine; no burning, itching or discharge"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No dizziness on standing; no ankle swelling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 122/78, pulse 70; weight 80.9 kg, BMI 27.0"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no edema; no fall in blood pressure on standing"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; liver edge not felt"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic kidney disease G3b A2",
              "assessment": "eGFR 40, from 44, two weeks after dapagliflozin: the expected early dip of about 9 percent, well within the 30 percent accepted; potassium 4.7 mmol/L. Urine albumin 96 mg/g, down 60 percent from 240. Stage G3b A2",
              "plan": [
                "Continue losartan 100 mg and dapagliflozin 10 mg",
                "Creatinine, eGFR, urine albumin and potassium in three months, then twice a year; calcium, phosphate and PTH in six months",
                "Nephrology review in three weeks, three months after the consultation"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertensive chronic kidney disease",
              "assessment": "122/78 by standardized measurement, close to a systolic target below 120",
              "plan": [
                "If systolic stays above 120 at three months, add amlodipine 5 mg"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Alcohol use disorder, severe, in early recovery (early remission needs three months without criteria)",
              "assessment": "Eight weeks abstinent with PEth 6 ng/mL; liver tests and MCV normal. AUDIT 9 for the past three months. Safety reviewed: no thoughts of suicide or self-harm, firearms locked, 988 card carried",
              "plan": [
                "Continue naltrexone for at least a year",
                "Counseling every two weeks from now",
                "PEth every two to three months"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Cigarette smoking",
              "assessment": "Ready to set a quit date in the new year",
              "plan": [
                "Nicotine patch with a short-acting form, or varenicline, at the next visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Standardized office blood pressure (five minutes' rest, validated device, average of readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "122/78 mmHg; home average 120/76",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine after starting or changing losartan or an SGLT2 inhibitor",
              "cadence": "Two to four weeks after each start or change",
              "status": "completed_today",
              "detail": "Two weeks after dapagliflozin: potassium 4.7 mmol/L; creatinine 2.13 mg/dL, an expected 9 percent fall in eGFR",
              "observation_ids": [
                "OBS-K-V5",
                "OBS-CR-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine with eGFR and urine albumin-to-creatinine ratio",
              "cadence": "G3b A2: twice a year, and at each medicine check",
              "status": "completed_today",
              "detail": "eGFR 40; urine albumin 96 mg/g",
              "observation_ids": [
                "OBS-EGFR-V5",
                "OBS-UACR-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Electrolytes and bicarbonate",
              "cadence": "With each kidney test",
              "status": "completed_today",
              "detail": "Sodium 139; bicarbonate 23; urea nitrogen 24 mg/dL",
              "observation_ids": [
                "OBS-NA-V5",
                "OBS-CO2-V5",
                "OBS-BUN-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium, phosphate and PTH",
              "cadence": "G3a to G3b: every six to twelve months",
              "status": "up_to_date",
              "detail": "Due in six months",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "SGLT2 inhibitor safety: sick-day rules, ketoacidosis, genital infection, volume",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No genital infection, dizziness or illness; sick-day rules understood",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication reconciliation: no NSAIDs, kidney dosing, contrast safety",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No NSAIDs; all doses checked for his eGFR",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Lifestyle: sodium below 2 g a day, activity, diet, weight",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Less salt; swims or rides most days; 3.3 kg lost",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccination review (pneumococcal, influenza, hepatitis B, COVID-19)",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "Second hepatitis B dose today; influenza, PCV20 and hepatitis A given at the preventive visit",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking since the last visit (self-report)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None for eight weeks",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "PEth",
              "cadence": "At baseline and every four to six weeks in early recovery",
              "status": "completed_today",
              "detail": "6 ng/mL: abstinence",
              "observation_ids": [
                "OBS-PETH-V5"
              ],
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "AUDIT",
              "cadence": "At intake and at three months",
              "status": "completed_today",
              "detail": "9 for the past three months, from 27",
              "observation_ids": [
                "OBS-AUDIT-V5"
              ],
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT) on naltrexone",
              "cadence": "At baseline, at four to six weeks, then every few months",
              "status": "completed_today",
              "detail": "AST 29, ALT 26, GGT 54 U/L; MCV 96 fL",
              "observation_ids": [
                "OBS-AST-V5",
                "OBS-ALT-V5",
                "OBS-GGT-V5",
                "OBS-MCV-V5"
              ],
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021",
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone safety: opioid use, nausea, wallet card",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No nausea; no opioid",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Addiction-focused counseling and mutual help",
              "cadence": "Weekly in early recovery, then every two weeks",
              "status": "completed_today",
              "detail": "Ten sessions; every two weeks from now",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9 and GAD-7",
              "cadence": "At intake and at follow-up",
              "status": "completed_today",
              "detail": "PHQ-9 4 with item 9 scored 0; GAD-7 4",
              "observation_ids": [
                "OBS-PHQ9-V5",
                "OBS-GAD7-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, firearms storage, safety plan and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; firearms locked; 988 card carried",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use and readiness to stop",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Ready to set a quit date",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            }
          ],
          "follow_up": "Nephrology review in three weeks. Primary care in three months with creatinine, eGFR, urine albumin, potassium and PEth. Counseling every two weeks. The clinic or 988 at any hour",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-APA-AUD-2018",
            "GL-SUD-2021",
            "GL-AASLD-ALD-2019",
            "GL-SUICIDE-2024",
            "GL-USPSTF-TOB-2021"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-09-29",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on paper in the waiting room and reviewed with him by Dr. Whitcombe-Ibe",
          "hpi": {
            "narrative": "Mr. London is a 39-year-old writer with chronic kidney disease G3b A2 from hypertension and past naproxen use, severe alcohol use disorder in early recovery on naltrexone, alcohol-associated fatty liver and cigarette smoking, who comes for his preventive visit two weeks after his six-week review. He has not had a drink since the single evening four weeks ago after he sprained his ankle; the ankle is nearly back to normal. He writes every morning and has taken up a swim at the time he used to have his first drink. He has taken losartan 100 mg for two weeks without dizziness. His hepatitis B, hepatitis C and HIV tests drawn at the consultation were negative. He has not had an influenza or pneumococcal vaccine in years and has never had hepatitis A or B vaccines; his last tetanus booster was six years ago. He has not seen a dentist in several years.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 39"
              },
              {
                "label": "Alcohol",
                "value": "No drink for four weeks; naltrexone daily"
              },
              {
                "label": "Kidneys",
                "value": "eGFR 44 two weeks ago; urine albumin 128 mg/g"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 1"
              },
              {
                "label": "Medicines",
                "value": "Losartan 100 mg, naltrexone 50 mg, thiamine 100 mg and vitamin D3 25 micrograms daily; acetaminophen as needed"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair, and better than in the summer"
            },
            {
              "domain": "Psychosocial",
              "finding": "Married; money worries over the ranch; writing steadily; sees the addiction counselor weekly"
            },
            {
              "domain": "Alcohol",
              "finding": "Abstinent for four weeks after one lapse; AUDIT 27 at intake"
            },
            {
              "domain": "Tobacco",
              "finding": "About ten cigarettes a day"
            },
            {
              "domain": "Physical activity",
              "finding": "Swims most days; riding again since the sprain healed"
            },
            {
              "domain": "Nutrition",
              "finding": "Two meals a day now, less salt, more vegetables; still a lot of red meat"
            },
            {
              "domain": "Sleep",
              "finding": "Six hours, better than in the first weeks without alcohol"
            },
            {
              "domain": "Safety",
              "finding": "Firearms locked in the ranch office safe with the ammunition apart; seat belt; no driving after any drink"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No problems; reads for many hours a day"
            },
            {
              "domain": "Oral health",
              "finding": "No dental visit for several years; some loose teeth"
            },
            {
              "domain": "Sexual health",
              "finding": "One partner"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy better; no fevers; weight down 2.2 kg"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Some loose teeth; no pain"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations; ankle swelling gone"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Morning smoker's cough"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, bleeding or abdominal pain"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No flank pain, blood in the urine or change in passing urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Knee and low back ache after riding; right ankle almost normal"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or sores"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor now; no numbness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steadier; PHQ-2 1; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 82.0 kg, BMI 27.4; blood pressure 130/82; pulse 74 and regular"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "finding": "Gum recession with plaque; two lower teeth slightly loose"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Abdomen",
              "finding": "Liver edge not felt; no tenderness"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Right ankle without swelling; full range of movement"
            },
            {
              "system": "Skin",
              "finding": "No rash, sores or spider angiomas"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated for chronic kidney disease, alcohol use disorder, liver disease and smoking. Lipids at intake (LDL 128 mg/dL) and his age, with no diabetes or heart disease, do not call for a statin under KDIGO or USPSTF",
              "plan": [
                "Influenza, PCV20, hepatitis B (first dose) and hepatitis A (first dose) vaccines today; second hepatitis B dose in four weeks; second hepatitis A dose in six months; COVID-19 vaccine at the pharmacy this month",
                "Dental examination and cleaning",
                "Nicotine replacement offered again; he will decide at the next visit",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Alcohol use disorder, severe, in early recovery",
              "assessment": "Abstinent for four weeks since one lapse; safety reviewed: no thoughts of suicide or self-harm, firearms locked, 988 card carried",
              "plan": [
                "Continue naltrexone and weekly counseling"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure",
              "status": "completed_today",
              "detail": "130/82 mmHg on losartan 100 mg; target below 120 systolic if tolerated",
              "guideline_ids": [
                "GL-KDIGO-BP-2021",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "service": "Lipid screening and cardiovascular risk",
              "status": "up_to_date",
              "detail": "Lipid panel once at the kidney diagnosis; statin not indicated at 39 without diabetes, heart disease or stroke",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-USPSTF-STATIN-2022"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "up_to_date",
              "detail": "HbA1c 5.4% at intake",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "not_indicated",
              "detail": "From 45",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "From 50 with 20 pack-years",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tobacco cessation",
              "status": "completed_today",
              "detail": "Advised to stop; nicotine replacement and varenicline offered; he wants to wait until he is surer of his sobriety",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            },
            {
              "service": "Unhealthy alcohol use",
              "status": "up_to_date",
              "detail": "Alcohol use disorder in treatment; naltrexone and weekly counseling",
              "guideline_ids": [
                "GL-APA-AUD-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 1",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "HIV screening",
              "status": "up_to_date",
              "detail": "Negative at the consultation",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "up_to_date",
              "detail": "Negative at the consultation",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening",
              "status": "up_to_date",
              "detail": "Triple panel negative at the consultation; not immune",
              "guideline_ids": [
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "completed_today",
              "detail": "First HepB-CpG dose today; second in four weeks",
              "guideline_ids": [
                "GL-ACIP-HBV-2022",
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Hepatitis A vaccine",
              "status": "completed_today",
              "detail": "First dose today for chronic liver disease; second in six months",
              "guideline_ids": [
                "GL-ACIP-HAV-2020"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 today for chronic kidney disease, alcohol use disorder and smoking",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "This season's dose today",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "due",
              "detail": "This season's dose at the pharmacy this month",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Booster six years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Dental examination",
              "status": "due",
              "detail": "No visit for several years; gum disease and loose teeth; booked",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent and completed a health care proxy form; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think clearly and write, and to live on the ranch. He chose not to record specific treatment preferences now; the plan will be revisited if his kidney function falls further, and before any discussion of dialysis.",
          "follow_up": "Ten-week review in two weeks with potassium, creatinine and PEth. Second hepatitis B dose at the twelve-week review. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-MC-2026",
            "GL-ACIP-HBV-2022",
            "GL-ACIP-HAV-2020",
            "GL-USPSTF-TOB-2021",
            "GL-KDIGO-CKD-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Same-day sick visit for a right ankle sprain",
        "status": "finished",
        "date": "2026-09-01",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Painful, swollen right ankle since yesterday evening",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. London asked for a same-day visit. Yesterday evening, walking the pasture at dusk, he stepped into a burrow and turned his right foot inward; he felt a sharp pain on the outside of the ankle and limped back to the house. The ankle swelled overnight. He took two acetaminophen tablets and, he says, two large glasses of whisky for the pain: the first alcohol since he stopped 27 days ago. He did not take naproxen, though there was still a bottle in the house; he has thrown it out this morning. He walked in from the car with a limp. He has had no thoughts of harming himself and the firearms are still locked away. He takes naltrexone every morning and asks whether he can have something stronger for the pain.",
            "elements": [
              {
                "label": "Onset",
                "value": "Yesterday evening, an inversion injury"
              },
              {
                "label": "Location",
                "value": "Outer side of the right ankle"
              },
              {
                "label": "Duration",
                "value": "About 16 hours"
              },
              {
                "label": "Character",
                "value": "Aching and throbbing; sharp on walking"
              },
              {
                "label": "Severity",
                "value": "6 of 10 when walking"
              },
              {
                "label": "Timing",
                "value": "Constant, worse on standing"
              },
              {
                "label": "Context",
                "value": "Chronic kidney disease; on naltrexone; one evening of drinking last night"
              },
              {
                "label": "Modifying factors",
                "value": "Acetaminophen and rest help; walking hurts"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Swelling and bruising; no numbness; no other injury"
              }
            ]
          },
          "ros": [
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Right ankle pain and swelling; no knee or foot pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling of the foot"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Ashamed of drinking last night; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; walks with a limp; blood pressure 142/88, pulse 88"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Swelling and bruising below and in front of the right lateral malleolus; tender over the anterior talofibular ligament; no tenderness at the posterior edge or tip of either malleolus, the navicular or the base of the fifth metatarsal; bears weight for four steps; anterior drawer test slightly lax compared with the left; knee normal"
            },
            {
              "system": "Neurological",
              "finding": "Sensation and pulses in the foot normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm, frank and a little downcast; no thoughts of suicide"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-008",
              "display": "Right ankle sprain",
              "assessment": "A moderate lateral ankle sprain. The Ottawa ankle rules are negative, so no X-ray is needed",
              "plan": [
                "Ice, compression and elevation for two to three days, a lace-up brace, and walking as pain allows, with ankle exercises from next week",
                "Acetaminophen up to 2,000 mg a day",
                "Diclofenac 1% gel to the ankle four times a day for up to seven days; no naproxen, ibuprofen or other anti-inflammatory tablets, which could harm his kidneys",
                "No opioid: naltrexone blocks it and an opioid would add risk in kidney disease and early recovery; if pain ever needs an opioid, it must be planned with this clinic"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Alcohol use disorder, severe, in early recovery",
              "assessment": "One evening of drinking after 27 days, set off by pain: a lapse, not a return to daily drinking. He told it plainly and wants to go on. Safety reviewed: no thoughts of suicide or self-harm; firearms still locked; 988 card carried",
              "plan": [
                "Continue naltrexone every morning",
                "Talk it through with the addiction counselor this week; a plan for pain and other triggers",
                "PEth at the six-week review"
              ]
            }
          ],
          "follow_up": "Six-week review in two weeks, or sooner for numbness, coldness of the foot, inability to bear weight, or any drinking he cannot stop. The clinic or 988 at any hour",
          "guideline_ids": [
            "GL-KDIGO-CKD-2024",
            "GL-APA-AUD-2018",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the injury is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-08-04",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 84.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 158,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 98,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs (standardized: five minutes' rest, validated device, average of three readings); no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-08-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 83.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 146,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 92,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs (standardized: five minutes' rest, validated device, average of three readings); no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-09-15",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 82.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 138,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 86,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs (standardized: five minutes' rest, validated device, average of three readings); no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-10-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 81.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs (standardized: five minutes' rest, validated device, average of three readings); no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 80.9,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs (standardized: five minutes' rest, validated device, average of three readings); no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-09-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 82.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 130,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic standardized seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-09-01",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 83.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 142,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 88,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 88,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic standardized seated vital signs at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Novelist and journalist, internationally known; writes a thousand words every morning from nine to eleven, six or seven days a week, under steady pressure to pay for the ranch and to help others; farms and breeds livestock on a large ranch in the Sonoma Valley",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0008",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to his documented writing and ranch.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Married; two daughters from an earlier marriage; lives on the ranch; back two weeks from five months in Hawaii",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic household history anchored to the documented marriages and dates; no relative is named or given a role in the modern episode.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Drinks whisky most days: the first drink when the morning's writing is done, more through the afternoon and evening, a bottle or more on most days for years, and a drink on waking some mornings to steady his hands; has tried to cut down on his own several times; AUDIT 27",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic alcohol history anchored to his own published account of heavy drinking; the amounts are synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Smokes about ten cigarettes a day; no other substances; no opioids or sleeping pills",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Eats one large meal a day, often rare meat, with little fruit or vegetables; heavy salt; rides and swims in the afternoons when he is well",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diet and activity history.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Keeps a rifle and a shotgun on the ranch for livestock and hunting",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic detail recorded for the safety assessment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-007",
        "display": "Strengths: an iron habit of daily work, curiosity and humor, his love of the ranch and the sea, a frank and detailed understanding of his own drinking, and his own decision to come in now",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic strengths anchored to his documented writing.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent; still writes every morning but tires by afternoon; rides less than he did; knee and low back pain after riding",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, warm and quick; speech fluent, at times emphatic; mood 'worn down'; affect full; slight tremor of the outstretched hands; no psychotic symptoms; no thoughts of suicide or of harming anyone; insight good and judgment fair; PHQ-9 9 with item 9 scored 0; GAD-7 7",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-08-04",
      "current_ideation": "absent",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "His daily work and the books he still means to write",
        "His ranch, its animals and its plans",
        "Humor and curiosity",
        "His own decision to seek help now",
        "Engagement in care, with a plan he helped write"
      ],
      "disposition": "Outpatient care with close follow-up. Risk factors reviewed without detail: severe alcohol use disorder, a new chronic illness, financial pressure, mild depressive and anxiety symptoms, and firearms on the ranch. He agreed that the rifle and shotgun will be kept locked in the ranch office safe with the ammunition stored apart, and that he will not handle them after drinking. Chlordiazepoxide is dispensed for five days only, with a daily telephone check. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) and the clinic's number were written on a card he carries. Safety is reviewed at every visit",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [
          "CLM-0008"
        ],
        "synthetic_reason": "Synthetic present-day structured safety assessment required by the alcohol use disorder code; it records no current suicidal ideation and makes no claim about his real mental health.",
        "author": "The Human Record generator",
        "created": "2026-11-05T15:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "Reduced kidney function (creatinine 1.98 mg/dL, eGFR 43) with albumin in the urine (240 mg/g) and untreated high blood pressure (158/98) in a 39-year-old writer with severe alcohol use disorder, who has taken naproxen most days for two years. Please confirm the stage and cause, and advise on blood pressure, an SGLT2 inhibitor, medicine for his alcohol use disorder at this kidney function, and pain relief",
        "urgency": "Within two weeks",
        "pertinent_history": "Tired by afternoon and ankles swelling for some months. Told his blood pressure was high a year ago; never treated. By his account, a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago; the report has been requested. Naproxen 500 mg twice daily, bought over the counter, most days for about two years for knee and back pain; stopped today. Drinks a bottle of whisky or more most days, with a morning drink some days; seven DSM-5-TR criteria (severe); AUDIT 27; PEth 410 ng/mL; plans to stop tomorrow with a five-day chlordiazepoxide taper (withdrawal-risk score low, no past seizures or delirium) and thiamine. Smokes ten cigarettes a day. No diabetes, kidney stones, gout attacks, blood in the urine, rash, or family history of kidney disease known. Kidney damage was mentioned to him at an abdominal operation some years ago. Examination: blood pressure 158/98, pulse 92, weight 84.2 kg, BMI 28.1; 1+ ankle edema; slight tremor; no rash; liver edge not felt. Results today: creatinine 1.98 mg/dL, eGFR 43, potassium 4.6, bicarbonate 22, urea nitrogen 28 mg/dL; urine albumin-to-creatinine ratio 240 mg/g; uric acid 8.4 mg/dL; calcium 9.2, phosphate 3.8 mg/dL, PTH 74 pg/mL; hemoglobin 13.6 g/dL, MCV 101 fL, platelets 182; AST 68, ALT 41, GGT 186 U/L, albumin 4.1 g/dL, bilirubin 0.9 mg/dL, INR 1.0 (FIB-4 2.28); HbA1c 5.4%; LDL 128 mg/dL. Started today: losartan 50 mg daily, chlordiazepoxide taper, thiamine, acetaminophen up to 2,000 mg a day in place of naproxen. Ultrasound of the kidneys and liver and liver elastography are booked for the morning of the consultation",
        "questions": [
          "Is this chronic kidney disease, what is its KDIGO stage, and what is the most likely cause: hypertension, naproxen, alcohol, stones, gout, or a disease that needs a biopsy?",
          "What blood pressure target and losartan dose do you advise, and how should potassium and creatinine be followed?",
          "Should he start an SGLT2 inhibitor now, given his heavy drinking?",
          "Which medicine for alcohol use disorder is safe at his kidney function (naltrexone or acamprosate), and is the outpatient withdrawal plan safe for his kidneys and liver?",
          "Which pain medicines are safe for him, and what should we avoid?"
        ]
      },
      "consultant_note": {
        "history": "Mr. London, 39, a novelist who writes every morning on his ranch, is seen at the request of Dr. Whitcombe-Ibe two weeks after reduced kidney function, albumin in the urine and high blood pressure were found, together with severe alcohol use disorder. He stopped drinking the day after the intake visit and completed a five-day chlordiazepoxide taper without complications; he has had no alcohol for twelve days. He stopped naproxen and takes acetaminophen. He has taken losartan 50 mg for two weeks without dizziness. He has never passed a stone or had gout, blood in the urine or a rash. He remembers being told years ago that his kidneys were damaged, at an operation for his appendix",
        "data_reviewed": "Dr. Whitcombe-Ibe's intake note and results: creatinine 1.98 mg/dL, eGFR 43, urine albumin-to-creatinine ratio 240 mg/g, uric acid 8.4 mg/dL, PTH 74 pg/mL, hemoglobin 13.6 g/dL, AST 68, ALT 41, GGT 186 U/L, FIB-4 2.28, PEth 410 ng/mL, HbA1c 5.4%. Urinalysis: 2+ protein, no blood, no casts or crystals. Insurance examination report: creatinine 1.7 mg/dL about fourteen months ago. Today: potassium 4.9 mmol/L, creatinine 2.04 mg/dL (eGFR 42), AST 49, ALT 36, GGT 141 U/L. Ultrasound this morning: kidneys 10.8 and 11.0 cm, echogenic, no stones, hydronephrosis or cysts; fatty liver; normal spleen. Elastography: liver stiffness 7.2 kPa, controlled attenuation parameter 312 dB/m. Kidney failure risk equation: five-year risk about 5 percent, two-year about 1.5 percent. Estimated creatinine clearance (Cockcroft-Gault) about 58 mL/min",
        "exam": [
          {
            "system": "General",
            "finding": "Well; blood pressure 146/92, pulse 84; weight 83.6 kg"
          },
          {
            "system": "Cardiovascular",
            "finding": "Regular rhythm; no murmur or bruit; trace ankle edema"
          },
          {
            "system": "Skin",
            "finding": "No rash, purpura or tophi"
          },
          {
            "system": "Neurological",
            "finding": "No tremor"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Chronic kidney disease G3b A2",
            "assessment": "Chronic kidney disease, stage G3b A2 by KDIGO 2024: an eGFR of 42 to 43 with albumin 240 mg/g, and a creatinine already 1.7 mg/dL fourteen months ago, so it has lasted more than three months; high risk on the KDIGO heat map. Normal-sized echogenic kidneys, a bland sediment without blood, moderate rather than heavy albuminuria and long-standing untreated hypertension point to hypertensive kidney disease, with two years of daily naproxen adding harm. There are no stones or obstruction, and no gout attacks; the uric acid of 8.4 mg/dL does not need treatment without gout. Alcohol raises blood pressure but is not itself a usual cause of this picture. Nothing suggests a glomerulonephritis or another disease that needs a biopsy now; hepatitis B, hepatitis C and HIV serology are drawn today, and a biopsy would be reconsidered for blood in the urine, rising albumin or a fall in eGFR without explanation. A cystatin C estimate is not needed now, since no decision hinges on it. 25-hydroxyvitamin D was not drawn and should be"
          },
          {
            "problem_id": "PRB-003",
            "display": "Blood pressure",
            "assessment": "Aim for a systolic below 120 by standardized office measurement if he tolerates it, as KDIGO 2021 advises, and at least below 130/80 as the 2025 AHA/ACC guideline does. Losartan should go to the maximum tolerated dose, 100 mg, because it lowers albuminuria as well as pressure; potassium 4.9 and a 3 percent rise in creatinine are acceptable. Check potassium and creatinine two to four weeks after each change; accept a creatinine rise of up to 30 percent. Less than 2 g of sodium a day; amlodipine would be the next step"
          },
          {
            "problem_id": "PRB-002",
            "display": "SGLT2 inhibitor",
            "assessment": "He meets the KDIGO 2024 recommendation for an SGLT2 inhibitor (eGFR 20 or more with albumin 200 mg/g or more), which slows kidney decline whether or not there is diabetes. But heavy drinking, missed meals and vomiting raise the risk of ketoacidosis on these drugs, even without diabetes. I advise waiting until he has been abstinent for some weeks and is eating regularly, then dapagliflozin 10 mg daily with written sick-day rules, and potassium and creatinine two to four weeks after starting, expecting an early dip in eGFR"
          },
          {
            "problem_id": "PRB-004",
            "display": "Medicine for alcohol use disorder",
            "assessment": "Naltrexone is the better choice. It is cleared mainly by the liver, needs no dose change at his kidney function, and his liver tests are falling and under three times normal; he takes no opioids. Acamprosate is cleared by the kidneys: at a creatinine clearance of 30 to 50 mL/min the dose must be cut to 333 mg three times a day and below 30 it should not be used, and with his clearance near 58 and likely to change, and a three-times-a-day schedule he says he would not keep, it is a second choice. The outpatient chlordiazepoxide taper was reasonable for his kidneys, since it is cleared by the liver, and safe for a liver without cirrhosis; in a man with cirrhosis or worse liver function a shorter-acting benzodiazepine would be preferred. Disulfiram is not advised"
          },
          {
            "problem_id": "PRB-006",
            "display": "Pain relief",
            "assessment": "No naproxen, ibuprofen, high-dose aspirin or other oral anti-inflammatory medicines, which cut kidney blood flow and caused part of this damage. Acetaminophen is the first choice, kept to 2,000 mg a day after heavy drinking. A short course of a topical anti-inflammatory gel on a small area is acceptable, because blood levels are low. No opioids or tramadol: naltrexone blocks opioids, morphine's active products build up when the kidneys are weak, and opioids add risk in early recovery. Any new medicine should be checked for kidney dosing, and iodinated contrast used only with precautions"
          }
        ],
        "recommendations": [
          "Chronic kidney disease G3b A2, most likely hypertensive with naproxen contributing; no biopsy now; hepatitis B, hepatitis C and HIV serology today; 25-hydroxyvitamin D with the next blood test",
          "Losartan raised to 100 mg at about six weeks if potassium allows, with potassium and creatinine two to four weeks after each change; systolic target below 120 if tolerated; sodium below 2 g a day; amlodipine next if needed",
          "Dapagliflozin 10 mg daily once he has been abstinent for some weeks and is eating regularly, with written sick-day rules and potassium and creatinine two to four weeks later",
          "Naltrexone 50 mg daily, with a wallet card and liver tests at four to six weeks; acamprosate only as a second choice at a reduced dose, and not below a creatinine clearance of 30",
          "No oral NSAIDs, no opioids or tramadol; acetaminophen up to 2,000 mg a day; topical gels for short courses only",
          "Creatinine, eGFR and urine albumin twice a year once stable; calcium, phosphate and PTH every six to twelve months; hemoglobin yearly; no statin now at 39 without diabetes or heart disease; no treatment for the uric acid without gout",
          "Pneumococcal, influenza, hepatitis B and COVID-19 vaccines"
        ],
        "communication": "Discussed with Dr. Whitcombe-Ibe, who saw him the same day. Mr. London asked plainly whether his kidneys would fail. He was told that his kidneys have lost about half their filtering, that the five-year risk of needing dialysis is about one in twenty, and that stopping alcohol and naproxen, controlling blood pressure and the two kidney-protecting medicines can slow or halt the decline. He chose naltrexone and agreed to wait for dapagliflozin",
        "follow_up": "Dr. Whitcombe-Ibe continues care at six, ten and twelve weeks; nephrology review in three months, or sooner for potassium above 5.5 mmol/L, a creatinine rise of more than 30 percent, blood in the urine, or rising albumin"
      },
      "guideline_ids": [
        "GL-KDIGO-CKD-2024",
        "GL-KDIGO-BP-2021",
        "GL-AHA-HTN-2025",
        "GL-APA-AUD-2018",
        "GL-SUD-2021",
        "GL-ASAM-AWM-2020",
        "GL-CMID-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Tired by afternoon, with swollen ankles, and frightened by the word 'kidneys' again",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to his documented kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He knows the drinking is hurting him and wants to stop without losing his work",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to his own account of drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He wants to keep writing a thousand words every morning",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to his documented writing.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Find out how much kidney function is lost, how long it has been so, and why",
        "status": "completed",
        "target_date": "2026-08-18",
        "outcome": "Chronic kidney disease G3b A2 from hypertension with naproxen contributing; no stones, obstruction or glomerular disease suspected",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Stop drinking safely, and stay stopped",
        "status": "active",
        "target_date": "2027-02-02",
        "outcome": "Withdrawal completed without complications; one evening of drinking at four weeks; abstinent since, with PEth 8 and then 6 ng/mL",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic goal set with the patient.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Blood pressure below 120 systolic by standardized office measurement if tolerated, and at least below 130/80",
        "status": "active",
        "target_date": "2027-02-02",
        "outcome": "158/98 to 122/78 at twelve weeks on losartan 100 mg",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Urine albumin down by at least 30 percent",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "240 to 96 mg/g on losartan and then dapagliflozin",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic albuminuria goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "No anti-inflammatory pain medicines, and pain controlled",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "No naproxen since intake; acetaminophen and topical treatment only, including for an ankle sprain",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic medication-safety goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Keep the morning writing hours",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "Wrote every morning through the twelve weeks except the two days of the worst withdrawal",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic goal set with the patient.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Kidneys and blood pressure: creatinine with eGFR (CKD-EPI 2021), urine albumin-to-creatinine ratio and urinalysis with microscopy, electrolytes and bicarbonate, uric acid, calcium, phosphate and PTH, blood count, HbA1c and a lipid panel once; the earlier insurance creatinine obtained; ultrasound of the kidneys and liver; standardized office blood pressure at every visit and home readings",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-KDIGO-BP-2021",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Nephrology consultation to confirm the stage and cause of the kidney disease and advise on blood pressure, an SGLT2 inhibitor, medicines for alcohol use disorder at his kidney function, and pain relief",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-KDIGO-BP-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Losartan 50 mg daily from intake, raised to the maximum tolerated dose, with potassium and creatinine two to four weeks after each start or change, accepting a rise in creatinine of up to 30 percent; less salt",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-BP-2021",
          "GL-AHA-HTN-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure and albuminuria plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Alcohol: AUDIT, DSM-5-TR criteria and PEth with consent; liver tests and FIB-4; a withdrawal-risk score (PAWSS) and outpatient withdrawal with a five-day chlordiazepoxide taper, daily telephone checks and thiamine; addiction-focused counseling with the clinic's addiction medicine team each week and mutual-help meetings if he wishes; PEth and liver tests at follow-up",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-AUD-2018",
          "GL-SUD-2021",
          "GL-ASAM-AWM-2020",
          "GL-AASLD-NIT-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic alcohol plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Medicine for alcohol use disorder: naltrexone 50 mg daily, which needs no dose change at his kidney function, with liver tests and a wallet card about opioid blockade; acamprosate not chosen because it needs a lower dose at his creatinine clearance and is avoided below 30 mL/min, and he could not reliably take it three times a day",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-AUD-2018",
          "GL-SUD-2021",
          "GL-KDIGO-CKD-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic medicine decision made at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-006",
        "display": "Liver: ultrasound and vibration-controlled transient elastography for an indeterminate FIB-4; abstinence as the treatment",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-ALD-2019",
          "GL-AASLD-NIT-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic liver plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-007",
        "display": "SGLT2 inhibitor (dapagliflozin 10 mg daily) once he has been abstinent for some weeks and is eating regularly, because heavy drinking and fasting raise the risk of ketoacidosis; held on days he cannot eat or drink, with potassium and creatinine two to four weeks after starting, accepting an early fall in eGFR",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic SGLT2 inhibitor plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-008",
        "display": "Pain and medicine safety: no naproxen, ibuprofen or other oral anti-inflammatory medicines; acetaminophen up to 2,000 mg a day; no opioids or tramadol with kidney disease and in early recovery, and none at all if naltrexone is started; any new medicine checked for kidney dosing",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic medication-safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "INT-009",
        "display": "Safety: a structured safety assessment, firearms locked with ammunition apart, small supplies of withdrawal medicine, a written safety plan, the 988 Suicide & Crisis Lifeline, and safety review at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-SUICIDE-2024",
          "GL-USPSTF-DEP-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "INT-010",
        "display": "Work and recovery: keep the morning writing hours from nine to eleven; replace the late-morning drink with a swim or a ride; no alcohol kept in the writing room; PHQ-9 and GAD-7 at intake and follow-up",
        "status": "completed",
        "guideline_ids": [
          "GL-SUD-2021",
          "GL-USPSTF-DEP-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic plan built around his writing schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "INT-011",
        "display": "Tobacco: advice to stop, with nicotine replacement or varenicline offered when he is ready",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-TOB-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic tobacco plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-KDIGO-CKD-2024",
        "title": "KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney Int 2024;105(4S):S117-S314)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38490803/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-KDIGO-BP-2021",
        "title": "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney International)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33637192/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-AHA-HTN-2025",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults",
        "publisher": "American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40811497/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension and depression monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-APA-AUD-2018",
        "title": "The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder",
        "publisher": "American Psychiatric Association (Am J Psychiatry 2018;175(1):86-90)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29301420/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-SUD-2021",
        "title": "VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://www.healthquality.va.gov/guidelines/MH/sud/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASAM-AWM-2020",
        "title": "The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management",
        "publisher": "American Society of Addiction Medicine (Journal of Addiction Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32511109/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-AASLD-ALD-2019",
        "title": "Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases",
        "publisher": "American Association for the Study of Liver Diseases (Hepatology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31314133/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-AASLD-NIT-2025",
        "title": "AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis",
        "publisher": "American Association for the Study of Liver Diseases (Hepatology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38489523/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-TOB-2021",
        "title": "Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CDC-HBV-2023",
        "title": "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36893044/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-ACIP-HBV-2022",
        "title": "Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices, United States, 2022",
        "publisher": "Centers for Disease Control and Prevention (MMWR 2022;71(13):477-483)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35358162/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ACIP-HAV-2020",
        "title": "Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recomm Rep 2020;69(5):1-38)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32614811/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CDC-IMZ-MC-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the CKD staging (G3b A2) and the attribution to hypertension and naproxen without a biopsy, losartan to the maximum dose with potassium checks, the systolic target, the delay of dapagliflozin until abstinence because of ketoacidosis risk, naltrexone over acamprosate at his kidney function, outpatient chlordiazepoxide withdrawal, the elastography interpretation, no treatment of asymptomatic high uric acid, the analgesic plan and the topical diclofenac for the sprain, the safety assessment and firearm storage, and the vaccinations."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: Jack London State Historic Park (the biography and three park historian or docent documents, one citing the death certificate and Huntington Library correspondence), California State Parks, his own accounts in The Cruise of the Snark and John Barleycorn (Project Gutenberg), and the PubMed records of Bomback and Klemmer (2007, 2008), Denko (1993) and Aronica and Norton (2015). The Huntington Library, Sonoma State University and Library of Congress pages could not be read. The roster's depression and probable bipolar disorder are not used as diagnoses."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Alcohol, mood and the disputed morphine and suicide story are marked sensitive. The morphine question is recorded once, plainly, as disputed later history, with neither side adopted, and is not used in the modern episode or shown in the intake documents. His drinking is described in his own published words and the modern alcohol use disorder is synthetic. A structured safety assessment with lethal-means counseling and the 988 line is recorded, and safety is reviewed at every visit. His relatives appear only as documented history; no relative has a role in the modern episode."
    }
  }
}
